Montelukast Prescribing at GODIVA GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,150
Total Quantity
31.8K
NHS Cost
£1.6K
vs National Avg
+68%
GODIVA GROUP PRACTICE prescribed 1,150 items of Montelukast over the last 12 months at a cost of £1,552 to the NHS. This is 68% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
100
Jun 2026
100
Jun 2026
110
Jun 2026
90
Jun 2026
93
Jun 2026
114
Jun 2026
87
Jun 2026
87
Jun 2026
106
Jun 2026
94
Jun 2026
80
Jun 2026
89
Prescribing Details
| Total Items | 1,150 |
|---|---|
| Total Quantity | 31,822 |
| Total NHS Cost | £1,552 |
| Presentations | 4 different forms |
| vs National Average | +68% |
Montelukast Prescribing Comparison
| This practice | 1,150 items |
|---|---|
| National average per practice | 685 items |
| Difference | +68% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.